Literature DB >> 33566198

Unravelling Toxoplasma treatment: conventional drugs toward nanomedicine.

Sanaz Jafarpour Azami1,2, Hanieh Mohammad Rahimi1, Hamed Mirjalali3, Mohammad Reza Zali4.   

Abstract

Toxoplasma gondii is a worldwide protozoan parasite that infects almost all warm-blooded animals. Although human toxoplasmosis is mostly latent, pregnant women and immunocompromised patients need effective treatment. There are drugs of choice for treatment of toxoplasmosis; however, due to their side effects and/or their disease stage-specificity, prescription of them is limited. During recent years, nanomedicine has been employed to overcome limitations of conventional drugs. Here, we provided a state-of-the-art review of experimental toxoplasmosis treatment using nanotechnology.

Entities:  

Keywords:  Acute toxoplasmosis; Chronic toxoplasmosis; Conventional therapy; Nanomedicine; Toxoplasma gondii; Treatment

Year:  2021        PMID: 33566198     DOI: 10.1007/s11274-021-03000-x

Source DB:  PubMed          Journal:  World J Microbiol Biotechnol        ISSN: 0959-3993            Impact factor:   3.312


  43 in total

Review 1.  Plant products as antimicrobial agents.

Authors:  M M Cowan
Journal:  Clin Microbiol Rev       Date:  1999-10       Impact factor: 26.132

Review 2.  Antiparasitic agent atovaquone.

Authors:  Aaron L Baggish; David R Hill
Journal:  Antimicrob Agents Chemother       Date:  2002-05       Impact factor: 5.191

3.  Isoenzyme analysis of 35 Toxoplasma gondii isolates and the biological and epidemiological implications.

Authors:  M L Dardé; B Bouteille; M Pestre-Alexandre
Journal:  J Parasitol       Date:  1992-10       Impact factor: 1.276

Review 4.  Host persistence: exploitation of anti-inflammatory pathways by Toxoplasma gondii.

Authors:  Julio Aliberti
Journal:  Nat Rev Immunol       Date:  2005-02       Impact factor: 53.106

5.  Metal nanoparticles restrict the growth of protozoan parasites.

Authors:  Oluyomi Stephen Adeyemi; Nthatisi Innocentia Molefe; Oluwakemi Josephine Awakan; Charles Obiora Nwonuma; Omokolade Oluwaseyi Alejolowo; Tomilola Olaolu; Rotdelmwa Filibus Maimako; Keisuke Suganuma; Yongmei Han; Kentaro Kato
Journal:  Artif Cells Nanomed Biotechnol       Date:  2018-07-22       Impact factor: 5.678

6.  Unique cellular interaction of silver nanoparticles: size-dependent generation of reactive oxygen species.

Authors:  C Carlson; S M Hussain; A M Schrand; L K Braydich-Stolle; K L Hess; R L Jones; J J Schlager
Journal:  J Phys Chem B       Date:  2008-10-03       Impact factor: 2.991

7.  Triclosan resistance reversion by encapsulation in chitosan-coated-nanocapsule containing α-bisabolol as core: development of wound dressing.

Authors:  João Guilherme B De Marchi; Denise S Jornada; Fernanda K Silva; Ana L Freitas; Alexandre M Fuentefria; Adriana R Pohlmann; Silvia S Guterres
Journal:  Int J Nanomedicine       Date:  2017-10-25

8.  Inorganic nanoparticles kill Toxoplasma gondii via changes in redox status and mitochondrial membrane potential.

Authors:  Oluyomi Stephen Adeyemi; Yuho Murata; Tatsuki Sugi; Kentaro Kato
Journal:  Int J Nanomedicine       Date:  2017-02-28

9.  Curcumin nanoemulsion as a novel chemical for the treatment of acute and chronic toxoplasmosis in mice.

Authors:  Sanaz Jafarpour Azami; Aref Teimouri; Hossein Keshavarz; Amir Amani; Fariba Esmaeili; Hamid Hasanpour; Samira Elikaee; Hamid Salehiniya; Saeedeh Shojaee
Journal:  Int J Nanomedicine       Date:  2018-11-09

Review 10.  Toxicity of Nanoparticles and an Overview of Current Experimental Models.

Authors:  Haji Bahadar; Faheem Maqbool; Kamal Niaz; Mohammad Abdollahi
Journal:  Iran Biomed J       Date:  2015-08-19
View more
  1 in total

1.  Formulation of Neem oil-loaded solid lipid nanoparticles and evaluation of its anti-Toxoplasma activity.

Authors:  Sara Nemati; Hanieh Mohammad Rahimi; Zahra Hesari; Meysam Sharifdini; Nooshin Jalilzadeh Aghdam; Hamed Mirjalali; Mohammad Reza Zali
Journal:  BMC Complement Med Ther       Date:  2022-05-04
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.